(0.16%) 5 162.75 points
(0.13%) 38 881 points
(0.12%) 18 023 points
(0.95%) $78.85
(0.56%) $2.15
(1.00%) $2 331.60
(2.61%) $27.39
(0.56%) $970.75
(0.04%) $0.929
(-0.29%) $10.84
(-0.19%) $0.796
(0.16%) $91.60
2 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 1.47%
Live Chart Being Loaded With Signals
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally...
Stats | |
---|---|
今日成交量 | 10 000.00 |
平均成交量 | 12 648.00 |
市值 | 8.60M |
EPS | $0 ( 2024-03-13 ) |
下一个收益日期 | ( $0 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.30 |
ATR14 | $0 (0.00%) |
Crescita Therapeutics Inc 相关性
10 最正相关 | |
---|---|
FM.TO | 0.895 |
SKE.TO | 0.869 |
HOT-UN.TO | 0.859 |
CJR-B.TO | 0.855 |
GOOS.TO | 0.854 |
USA.TO | 0.849 |
TNT-UN.TO | 0.846 |
CRWN.TO | 0.844 |
ERO.TO | 0.837 |
JOY.TO | 0.831 |
10 最负相关 | |
---|---|
HAC.TO | -0.879 |
SFC.TO | -0.869 |
E.TO | -0.858 |
THNC.TO | -0.844 |
CIA.TO | -0.827 |
SBB.TO | -0.825 |
EMP-A.TO | -0.824 |
SJ.TO | -0.814 |
RQN.TO | -0.813 |
ATE.TO | -0.809 |
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Crescita Therapeutics Inc 财务报表
Annual | 2023 |
营收: | $17.52M |
毛利润: | $8.86M (50.55 %) |
EPS: | $-0.0980 |
FY | 2023 |
营收: | $17.52M |
毛利润: | $8.86M (50.55 %) |
EPS: | $-0.0980 |
FY | 2022 |
营收: | $23.53M |
毛利润: | $13.18M (56.03 %) |
EPS: | $0.0417 |
FY | 2021 |
营收: | $16.77M |
毛利润: | $10.01M (59.72 %) |
EPS: | $-0.0500 |
Financial Reports:
No articles found.
Crescita Therapeutics Inc
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including MMPE and DuraPeel for the development of topicals containing cannabis and hemp. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination with MMPE technology to treat plaque psoriasis; CTX-102, a Phase I topical formulation utilizing MMPE technology to treat an undisclosed dermatological skin condition; and dermatology products in pre-clinical formulation utilizing MMPE technology for prescription treatments of skin diseases. Its non-prescription skincare products comprise skincare products, such as facial creams, cleansers, exfoliants, masks, serums, and suncare products for aging, acne, rosacea, pigmentation, dehydration, and sensitivity under the Laboratoire Dr Renaud brand; a line of dermocosmetic products for anti-aging medical procedures under the Pro-Derm brand; a line of products to target and treat various skincare concerns under the Alyria brand; and skincare products primarily for the Asian consumers under Dermazulene brand, as well as NCTF 135 HA, a skin revitalization solution primarily used for the improvement of skin quality and fine lines. The company has a development and licensing agreement with Sundial Growers Inc. to develop cannabis; a commercialization license agreement with Cantabria Labs Inc.; and a development and commercialization license agreement with Taro Pharmaceuticals Inc. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。